Validation of a metered dose inhaler electronic monitoring device: Implications for asthma clinical trial use

BMJ Open Respiratory Research

Volumn 3, Issue 1, 2016, Pages

  Pilcher, Janine ^a,b   Holliday, Mark ^b   Ebmeier, Stefan ^b   McKinstry, Steve ^b   Messaoudi, Fatiha ^b   Weatherall, Mark ^a,c   Beasley, Richard ^a,b  

^a CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

^b MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTHMA; COMPUTER PROGRAM; INSTRUMENT VALIDATION; MEASUREMENT ACCURACY; MEDICAL DEVICE; METERED DOSE INHALER; METERED DOSE INHALER ELECTRONIC MONITORING DEVICE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 85015978970     PISSN: None     EISSN: 20524439     Source Type: Journal    
DOI: 10.1136/bmjresp-2016-000128     Document Type: Article

References (13)

1. Riekert KA, Rand CS. Electronic monitoring of medication adherence: When is high-tech best? J Clin Psychol Med Settings 2002;9:25-34.
2. Patel M, Pilcher J, Chan A, et al. Six-month in vitro validation of a metered-dose inhaler electronic monitoring device: implications for asthma clinical trial use. J Allergy Clin Immunol Pract 2012;130:1420-2.
3. Patel M, Pilcher J, Pritchard A, et al. SMART Study Group. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet Respir Med 2013;1:32-42.
4. Patel M, Pilcher J, Travers J, et al. Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trial. J Allergy Clin Immunol Pract 2013;1:83-91.
5. Bender BG. Advancing the science of adherence measurement: implications for the clinician. J Allergy Clin Immunol Pract 2013;1:92-3.
6. GlaxoSmithKline NZ Limited. Ventolin® Inhaler (CFC-Free) data sheet version 4.0, 18 June 2014. http://www.medsafe.govt.nz/profs/datasheet/v/VentolinCFC-freeinh.pdf (accessed 13 Dec 2015).
7. Pilcher J, Shirtcliffe P, Patel M, et al. Three-month validation of a turbuhaler electronic monitoring device: implications for asthma clinical trial use. BMJ Open Respir Res 2015;2:e000097.
8. Foster JM, Smith L, Usherwood T, et al. The reliability and patient acceptability of the SmartTrack device: a new electronic monitor and reminder device for metered dose inhalers. J Asthma 2012;49:657-62.
9. Julius SM, Sherman JM, Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest 2002;121:871-6.
10. Patel M, Pilcher J, Reddel HK, et al. Metrics of salbutamol use as predictors of future adverse outcomes in asthma. Clin Exp Allergy 2013;43:1144-51.
11. Patel M, Pilcher J, Munro C, et al. Short-acting beta-agonist use as a marker of current asthma control. J Allergy Clin Immunol Pract 2013;1:370-7.
12. Pilcher J, Patel M, Smith A, et al. Combination budesonide/ formoterol inhaler as maintenance and reliever therapy in Maori with asthma. Respirology 2014;19:842-51.
13. Patel M, Pilcher J, Reddel HK, et al. Predictors of severe exacerbations, poor asthma control and B-agonist overuse for patients with asthma. J Allergy Clin Immunol Pract 2014;2:751-8.